Fast Company Executive Board
What agentic AI could fix for healthcare customer retention
The potential to scale customer engagement with personalization and precision.
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience.
Richard Mackey leads the IT organization at CCS, including digital strategy and infrastructure as Chief Technology Officer. His 20 years of experience managing technology at various leading organizations — including a strong focus on agile transformation, business analytics, and digital innovation — have enabled him to consistently and effectively improve organizational efficiencies and accelerate growth.
At CCS, Richard has been instrumental in reshaping the company’s systems and processes in order to improve the experience for patients, payors, providers, and employers. Richard and his team have been mission-critical in the company’s efforts to defragment the care experience for patients living with chronic diseases.
He helped transition CCS from a 30-year-old, traditional durable medical equipment company to an innovative, end-to-end chronic care engagement platform — integrating medical supplies, coaching, education, AI, and more to optimize outcomes for those living with chronic diseases, while also reducing total costs of care.
Previously, Richard was Senior Vice President, Technology and Products at Intalere, now a part of Vizient — a national healthcare group purchasing organization that also offers strategic services and solutions to companies across the healthcare spectrum. Prior to this, he has worked for a number of global life sciences and medical device companies, including Pfizer, Philips, and Novartis.
160 Fountain Pkwy N Suite 200 St. Petersburg, FL 33716-1205
Technology, AI, Innovation, Leadership, People Management
CCS is the strategic partner addressing America’s most pressing healthcare challenges through intelligent chronic care management, tackling the $412 billion annual diabetes burden and chronic conditions affecting over 133 million Americans. At the core of CCS’s differentiated model is LivingConnected®, a human-led, digitally enabled clinical solution. PropheSee™ — an AI-powered predictive model that identifies nonadherence risk and delivers personalized interventions — is an integral part of this solution, creating a first-of-its-kind platform to improve adherence, enhance clinical outcomes, and help prevent costly hospitalizations. By combining data-driven insights with three decades of industry relationships, CCS is the smart choice for health plans, providers, employers, and manufacturers who believe that value-based care starts by keeping patients healthy and delivers benefits like lower cost of care, improved HEDIS scores, and alleviating provider burnout. CCS’s approach extends clinical reach while supporting over 200,000 people nationwide with home-delivered medical supplies and pharmaceuticals annually. Recognized as a Great Place to Work® and with several peer-reviewed publications validating our care management approach, CCS is more than a trusted supplier — we’re a partner in transforming chronic care delivery.
Healthcare & Medical
Chronic disease, Diabetes, Technology, Patient Education and Coaching
Fast Company Executive Board
The potential to scale customer engagement with personalization and precision.
Welcome! We use cookies to track visitors to our site and personalize your experience.
If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.